cbdMD (YCBD) EBIAT (2016 - 2025)
cbdMD (YCBD) has disclosed EBIAT for 10 consecutive years, with -$283131.0 as the latest value for Q4 2025.
- Quarterly EBIAT fell 1975.66% to -$283131.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.3 million through Dec 2025, up 13.0% year-over-year, with the annual reading at -$2.0 million for FY2025, 44.84% up from the prior year.
- EBIAT hit -$283131.0 in Q4 2025 for cbdMD, up from -$679968.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of $1.5 million in Q2 2021 to a low of -$31.6 million in Q2 2022.
- Historically, EBIAT has averaged -$5.7 million across 5 years, with a median of -$1.6 million in 2023.
- Biggest five-year swings in EBIAT: plummeted 2157.79% in 2022 and later surged 125.97% in 2024.
- Year by year, EBIAT stood at -$19.2 million in 2021, then surged by 79.35% to -$4.0 million in 2022, then surged by 74.81% to -$996501.0 in 2023, then soared by 101.51% to $15095.0 in 2024, then plummeted by 1975.66% to -$283131.0 in 2025.
- Business Quant data shows EBIAT for YCBD at -$283131.0 in Q4 2025, -$679968.0 in Q3 2025, and -$895272.0 in Q2 2025.